BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8711595)

  • 21. [Future prospects for primary hormone therapy in localized and locally advanced prostate cancer].
    Akaza H; Hirao Y; Labrie F; Soloway MS
    Hinyokika Kiyo; 2003 Dec; 49(12):771-7. PubMed ID: 14978964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term results of adjuvant hormonal therapy plus radiotherapy following radical prostatectomy for patients with pT3N0 or pT3N1 prostate cancer.
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2004 Jun; 11(6):397-401. PubMed ID: 15157209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant hormonal ablative therapy before radical prostatectomy: a review. Is it indicated?
    Scolieri MJ; Altman A; Resnick MI
    J Urol; 2000 Nov; 164(5):1465-72. PubMed ID: 11025684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical management of lymph-node-positive prostate cancer: improves symptomatic control.
    Wiegand LR; Hernandez M; Pisters LL; Spiess PE
    BJU Int; 2011 Apr; 107(8):1238-42. PubMed ID: 20880197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No residual tumor in a radical prostatectomy specimen after neoadjuvant hormonal therapy for localized prostate cancer.
    Noguchi M; Noda S; Nakashima O; Kojiro M
    Oncol Rep; 2002; 9(5):1075-80. PubMed ID: 12168076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Radical prostatectomy with broadened scope of indications - analysis of early experience].
    Chakarov S; Bechev R; Lazarov Z; Fachikov Ts; Rangelov S
    Khirurgiia (Sofiia); 1999; 55(3):47-8. PubMed ID: 11194670
    [No Abstract]   [Full Text] [Related]  

  • 27. Role for androgen withdrawal prior to radiation and surgery for prostate cancer?
    Oncology (Williston Park); 1997 May; 11(5):738. PubMed ID: 9159797
    [No Abstract]   [Full Text] [Related]  

  • 28. [Neoadjuvant hormonal therapy before radical prostatectomy].
    Nakagawa T
    Nihon Rinsho; 2011 Jun; 69 Suppl 5():485-7. PubMed ID: 22208029
    [No Abstract]   [Full Text] [Related]  

  • 29. Neoadjuvant hormonal therapy in the management of prostate cancer: a surgical and radiation therapy review.
    Soderdahl DW; Wettlaufer JN; Corn B; Gomella LG
    Tech Urol; 1996; 2(4):194-206. PubMed ID: 9085540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is neoadjuvant hormonal therapy before radical prostatectomy indicated?
    Chun J; Pruthi RS
    Urol Int; 2004; 72(4):275-80. PubMed ID: 15153722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current world literature.
    Curr Opin Urol; 2013 Jul; 23(4):377-88. PubMed ID: 23735869
    [No Abstract]   [Full Text] [Related]  

  • 32. [Salvage radiotherapy in rising PSA after radical prostatectomy].
    Carrie C; Pommier P
    Cancer Radiother; 2007 Nov; 11(6-7):370-2. PubMed ID: 17869564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermittent complete androgen blockade in PSA relapse after radical prostatectomy and incidental prostate cancer.
    Kurek R; Renneberg H; Lübben G; Kienle E; Tunn UW
    Eur Urol; 1999; 35 Suppl 1():27-31. PubMed ID: 10081700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [What to do with a rising PSA after complete remission post-prostatectomy?].
    Bosset M; Bosset JF; Maingon P
    Cancer Radiother; 2006 Jun; 10(4):168-74. PubMed ID: 16529965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation: Five-year results.
    Homma Y; Akaza H; Okada K; Yokoyama M; Moriyama N; Usami M; Hirao Y; Tsushima T; Sakamoto A; Ohashi Y; Aso Y;
    Int J Urol; 2004 May; 11(5):295-303. PubMed ID: 15147545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment options after failure of local curative treatments in prostate cancer: a controversial issue.
    Schulman CC; Altwein JE; Zlotta AR
    BJU Int; 2000 Dec; 86(9):1014-22. PubMed ID: 11119094
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pro and contra -- adjuvant therapy in locoregional advanced prostatic carcinoma after radical prostatectomy].
    Hammerer P
    Aktuelle Urol; 2004 Sep; 35(5):371-2. PubMed ID: 15384001
    [No Abstract]   [Full Text] [Related]  

  • 38. Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study.
    Siddiqui SA; Boorjian SA; Inman B; Bagniewski S; Bergstralh EJ; Blute ML
    J Urol; 2008 May; 179(5):1830-7; discussion 1837. PubMed ID: 18353378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prostatectomy for prostate cancers].
    Ishida H; Hachiya T; Yamanaka Y; Okada K
    Gan To Kagaku Ryoho; 1998 May; 25(6):813-6. PubMed ID: 9617318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of prostate cancer].
    Romics I
    Orv Hetil; 2010 Apr; 151(14):580-3. PubMed ID: 20332076
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.